Angiotensin II as a cardiovascular risk factor (Q34610027)

3 August 2017

1 reference

title

Angiotensin II as a cardiovascular risk factor (English)

1 reference

3 August 2017

0 references

1 reference

Gavras I

1

1 reference

PubMed ID

11967726

3 August 2017

Gavras H

series ordinal

2

1 reference

3 August 2017

1 May 2002

1 reference

Journal of Human Hypertension

3 August 2017

1 reference

3 August 2017

16 Suppl 2

1 reference

3 August 2017

S2-6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001392

3 August 2017

0 references

cites work

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Cardiac myocyte necrosis induced by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

The effect of angiotensin converting enzyme inhibition on coronary blood flow and hemodynamics in patients without coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Ventricular myosin and creatine-kinase isoenzymes in hypertensive rats treated with captopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Cellular ras activity and phospholipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Growth factor-like action of phosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Circulating and tissue angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Extrarenal tissue prorenin systems do exist: are intrinsic vascular and cardiac tissue renins fact or fancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Oxidants, antioxidants, and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Activation of neurohumoral systems following acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Myocardial reperfusion: a double-edged sword?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Reactive oxygen species and antioxidant vitamins: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Plasma electrolytes in elderly patients taking fixed combination diuretics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Heart rhythms, ventricular arrhythmias,and death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Effects of Captopril on the Physical Work Capacity of Normotensive Patients with Stable-Effort Angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

ACE Inhibition with Cilazapril Improves Myocardial Perfusion to the Ischemic Regions During Exercise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Noradrenaline and cardiac hypertrophy in the rat: changes in morphology, blood pressure and ventricular performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Neuroendocrine changes in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Effects of angiotensin II on membrane current in cardiac Purkinje fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Is an intracellular renin-angiotensin system involved in control of cell communication in heart?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Cardiac refractoriness in rats is reduced by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Role for endothelin-1 in angiotensin II-mediated hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Mechanisms by which angiotensin II affects the heart rate of the conscious sheep

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Angiotensin induces inflammatory activation of human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001392

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001392

1 reference

PubMed ID

11967726

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

11967726